Research/art/teacher profile of a person
Name and surname:
MUDr. Kristína Repová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Repová
I.2 - Name
Kristína
I.3 - Degrees
MUDr., PhD.
I.4 - Year of birth
1984
I.5 - Name of the workplace
Department of Paediatrics
I.6 - Address of the workplace
Department of Paediatrics, Limbová 1, 833 40 Bratislava
I.7 - Position
Assistant Professor
I.8 - E-mail address
kristina.repova@fmed.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5648
I.10 - Name of the study field in which a person works at the university
Paediatrics
I.11 - ORCID iD
0000-0002-7235-1710

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University in Bratislava
II.b - Year
2009
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University in Bratislava
II.b - Year
2014
II.c - Study field and programme
Normal and Pathological Physiology
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Assistant Professor Department of Paediatrics 01.07.2024
Assistant Professor Institute of Pathological Physiology since 2014 - 30.06.2024
Assistant Institute of Pathological Physiology 2010 - 2013

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Medical Education Basics Institute of Medical Education and Simulations, FMCU 2024
Team-Based Learning Institute of Medical Education and Simulations, FMCU 2024
Effective Teaching for Internationalisation Comenius University in Bratisalva 2022
Vedecký kvalifikačný stupeň IIa Slovac Academy of Sciences 2019
Animal protection for scientific or educational purposes Veterinary Education Institute, Košice since 2017

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Paediatrics 1, 2 and 3 General Medicine I.+II. General Medicine
Pediatria 1, 2 a 3 všeobecné lekárstvo I.+II všeobecné lekárstvo
Paediatrics Dentistry I.+II. Dentistry
Pediatria zubné lekárstvo I.+II. zubné lekárstvo
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
2
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
9
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
105
VI.1.b - Over the last six years
23
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
33
VI.1.b - Over the last six years
14
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
414
VI.1.b - Over the last six years
59
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
411
VI.1.b - Over the last six years
54
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Repova K, Aziriova S, Krajcirovicova K, Simko F. Cardiovascular therapeutics: A new potential for anxiety treatment?. Med Res Rev. 2022;42(3):1202-1245. doi:10.1002/med.21875

2

Repova K, Baka T, Krajcirovicova K, et al. Melatonin as a Potential Approach to Anxiety Treatment. Int J Mol Sci. 2022;23(24):16187. Published 2022 Dec 19. doi:10.3390/ijms232416187

3

Simko F, Baka T, Krajcirovicova K, et al. Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension. Molecules. 2018;23(2):265. Published 2018 Jan 29. doi:10.3390/molecules23020265

4

Hrenak J, Paulis L, Repova K, et al. Melatonin and renal protection: novel perspectives from animal experiments and human studies (review). Curr Pharm Des. 2015;21(7):936-949. doi:10.2174/1381612820666140929092929

5

Simko F, Bednarova KR, Krajcirovicova K, et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J Pineal Res. 2014;57(2):177-184. doi:10.1111/jpi.12154

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Repova K, Aziriova S, Krajcirovicova K, Simko F. Cardiovascular therapeutics: A new potential for anxiety treatment?. Med Res Rev. 2022;42(3):1202-1245. doi:10.1002/med.21875

2

Repova K, Baka T, Krajcirovicova K, et al. Melatonin as a Potential Approach to Anxiety Treatment. Int J Mol Sci. 2022;23(24):16187. Published 2022 Dec 19. doi:10.3390/ijms232416187

3

Simko F, Baka T, Repova K, et al. Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol-induced myocardial injury. Fundam Clin Pharmacol. 2021;35(4):744-748. doi:10.1111/fcp.12620

4

Stanko P, Baka T, Repova K, et al. Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension. Front Med (Lausanne). 2020;7:325. Published 2020 Jul 10. doi:10.3389/fmed.2020.00325

5

Adamcova M, Baka T, Dolezelova E, et al. Relations between markers of cardiac remodelling and left ventricular collagen in an isoproterenol-induced heart damage model. J Physiol Pharmacol. 2019;70(1):10.26402/jpp.2019.1.08. doi:10.26402/jpp.2019.1.08

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Reiter RJ, Sharma R, Chuffa LGA, Simko F, Dominguez-Rodriguez A. Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure. Life (Basel). 2024;14(1):88. Published 2024 Jan 5. doi:10.3390/life14010088

2

Guedes MR, de Noronha SISR, Chírico MTT, da Costa GDC, de Freitas Castro T, de Brito RCF, Vieira LG, Reis TO, Ribeiro MC, Reis AB, Carneiro CM, Bezerra FS, Montano N, da Silva VJD, de Menezes RCA, Chianca-Jr DA, Silva FCDS. Ivabradine restores tonic cardiovascular autonomic control and reduces tachycardia, hypertension and left ventricular inflammation in post-weaning protein malnourished rats. Life Sci. 2024 Jun 1;346:122636. doi: 10.1016/j.lfs.2024.122636. Epub 2024 Apr 12. PMID: 38614307.

3

Strain MM, Conley NJ, Kauffman LS, et al. Dorsal motor vagal neurons can elicit bradycardia and reduce anxiety-like behavior. iScience. 2024;27(3):109137. Published 2024 Feb 6. doi:10.1016/j.isci.2024.109137

4

Xiong Z, Peng G, Deng J, et al. Therapeutic targets and potential delivery systems of melatonin in osteoarthritis. Front Immunol. 2024;15:1331934. Published 2024 Jan 24. doi:10.3389/fimmu.2024.1331934

5

El-Sayed SF, Abdelhamid AM, ZeinElabdeen SG, El-Wafaey DI, Moursi SMM. Melatonin enhances captopril mediated cardioprotective effects and improves mitochondrial dynamics in male Wistar rats with chronic heart failure. Sci Rep. 2024;14(1):575. Published 2024 Jan 5. doi:10.1038/s41598-023-50730-z

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

VEGA 1/0048/23: Protekcia kardiovaskulárneho systému pri experimentálnej hypertenzii a zlyhaní srdca inhibítorom sodíkovo–glukózového kotransportéra 2 – dapagliflozínom: Efekt na srdce, cievy a obličky. Porovnanie s ACE-inhibítorom kaptoprilom

2

VEGA 1-0035-19: Protekcia kardiovaskulárneho systému pri experimentálnej hypertenzii a zlyhaní srdca duálnou inhibíciou neprilyzínu a AT1 receptorov pre angiotenzín II: Porovnanie s ACE-inhibíciou a melatonínom

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-02-28